Qsemble Capital Management LP Lowers Stake in Agilent Technologies, Inc. $A

Key Points

• Qsemble Capital Management cut its Agilent Technologies stake by 77.4% in the second quarter, selling 80,925 shares and retaining 23,610 shares valued at approximately $3.14 million.
• Agilent reported quarterly earnings of $1.49 per share, above the $1.41 consensus estimate, while revenue rose 10% year over year to $1.83 billion. The company maintained FY 2026 EPS guidance of $6.00–$6.10.
• Wall Street maintains a “Moderate Buy” consensus on the stock, with a $160.24 average price target; Agilent also pays a quarterly dividend of $0.255 per share, yielding about 0.7%.

Qsemble Capital Management LP reduced its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 77.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,610 shares of the medical research company's stock after selling 80,925 shares during the period. Qsemble Capital Management LP's holdings in Agilent Technologies were worth $3,136,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also modified their holdings of A. Core Wealth Advisors LLC purchased a new position in Agilent Technologies during the 4th quarter valued at about $26,000. SHP Wealth Management purchased a new stake in Agilent Technologies during the fourth quarter worth about $26,000. Navalign LLC acquired a new stake in shares of Agilent Technologies during the fourth quarter worth about $27,000. Cedar Mountain Advisors LLC acquired a new stake in shares of Agilent Technologies during the first quarter worth about $27,000. Finally, MV Capital Management Inc. purchased a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $28,000. 87.41% of the stock is owned by institutional investors and hedge funds.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $148.55 on Friday. The business has a 50-day simple moving average of $135.38 and a 200-day simple moving average of $125.56. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27. The company has a market cap of $41.96 billion, a PE ratio of 29.83, a P/E/G ratio of 2.64 and a beta of 1.25.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.83 billion for the quarter, compared to analysts' expectations of $1.80 billion. During the same quarter last year, the company earned $1.31 earnings per share. The firm's revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 6.03 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were issued a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, June 30th. Agilent Technologies's dividend payout ratio (DPR) is presently 20.48%.

Wall Street Analyst Weigh In

A has been the subject of a number of research reports. Bank of America upgraded shares of Agilent Technologies from a "neutral" rating to a "buy" rating and dropped their price objective for the company from $150.00 to $145.00 in a report on Thursday, May 28th. Robert W. Baird raised their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an "outperform" rating in a research report on Tuesday, May 26th. HSBC dropped their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a research note on Wednesday, June 3rd. Piper Sandler began coverage on Agilent Technologies in a research report on Thursday, June 11th. They set a "neutral" rating and a $150.00 price objective on the stock. Finally, TD Cowen increased their price objective on Agilent Technologies from $147.00 to $155.00 and gave the company a "buy" rating in a research note on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $160.24.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source